Sangamo Therapeutics Inc (NASDAQ:SGMO)

8.32
Delayed Data
As of Oct 21
 +0.09 / +1.09%
Today’s Change
8.22
Today|||52-Week Range
19.43
-46.68%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 22.00, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +164.42% increase from the last price of 8.32.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$26.0M
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.09%
 
 
 
 
 
 
Growthannually -46.57%
 
 
 
 
 
 

Sales

Growthquarterly -6.86%
 
 
 
 
 
 
Growthannually -8.97%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.